Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in TaxesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Net Cash Flow (2022 - 2025)

Historic Net Cash Flow for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$7.6 million.

  • InflaRx's Net Cash Flow fell 19000.09% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.1 million, marking a year-over-year decrease of 46858.11%. This contributed to the annual value of $4.5 million for FY2024, which is 26720.28% up from last year.
  • As of Q3 2025, InflaRx's Net Cash Flow stood at -$7.6 million, which was down 19000.09% from -$36.9 million recorded in Q2 2025.
  • InflaRx's Net Cash Flow's 5-year high stood at $32.2 million during Q1 2025, with a 5-year trough of -$36.9 million in Q2 2025.
  • For the 4-year period, InflaRx's Net Cash Flow averaged around -$1.5 million, with its median value being -$1.2 million (2022).
  • Per our database at Business Quant, InflaRx's Net Cash Flow tumbled by 61618.96% in 2023 and then surged by 28435.13% in 2024.
  • Over the past 4 years, InflaRx's Net Cash Flow (Quarter) stood at -$1.2 million in 2022, then tumbled by 616.19% to -$8.8 million in 2023, then decreased by 12.95% to -$9.9 million in 2024, then rose by 22.97% to -$7.6 million in 2025.
  • Its last three reported values are -$7.6 million in Q3 2025, -$36.9 million for Q2 2025, and $32.2 million during Q1 2025.